Sonstiges: |
- Nachgewiesen in: MEDLINE
- Sprachen: English
- Publication Type: Case Reports; Journal Article
- Language: English
- [J Addict Nurs] 2021 Oct-Dec 01; Vol. 32 (4), pp. 260-262.
- MeSH Terms: COVID-19* ; Substance-Related Disorders* / complications ; Adult ; Cesarean Section ; Female ; Humans ; Mothers ; Placenta ; Pregnancy ; SARS-CoV-2
- References: Berghella V., Lim P. J., Hill M. K., Cherpes J., Chennat J., Kaltenbach K. (2003). Maternal methadone dose and neonatal withdrawal. American Journal of Obstetrics and Gynecology, 189(2), 312–317. https://doi.org/10.1067/S0002-9378(03)00520-9. (PMID: 10.1067/S0002-9378(03)00520-9) ; Chen H., Guo J., Wang C., Luo F., Yu X., Zhang W., Li J., Zhao D., Xu D., Gong Q., Liao J., Yang H., Hou W., Zhang Y. (2020). Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: A retrospective review of medical records. The Lancet, 395, 809–815 https://doi.org/10.1016/S0140-6736(20)30360-3. (PMID: 10.1016/S0140-6736(20)30360-3) ; Desai R. J., Hernandez-Diaz S., Bateman B. T., Huybrechts K. F. (2014). Increase in prescription opioid use during pregnancy among Medicaid-enrolled women. Obstetrics and Gynecology, 123(5), 997–1002. https://doi.org/10.1097/AOG.0000000000000208. (PMID: 10.1097/AOG.0000000000000208) ; Fältmarch S., Perttilä I., Tuomi U., Kautiainen H., Gissler M., Pennanen P., Eriksson J. G., Laine M. K. (2019). Use of opioids during pregnancy and effects of pregnancy outcomes. Pharmacoepidemiology and Drug Safety, 28(9), 1239–1245. https://doi.org/10.1002/pds.4848. (PMID: 10.1002/pds.4848) ; Favre G., Pomar L., Qi X., Nielsen-Saines K., Musso D., Baud D. (2020). Guidelines for pregnant women with suspected SARS-CoV-2 infection. The Lancet Infectious Diseases, 20, 652–653. https://doi.org/10.1016/S1473-3099(20)30157-2. (PMID: 10.1016/S1473-3099(20)30157-2) ; Giudicessi J. R., Noseworthy P. A., Friedman P. A., Ackerman M. J. (2020). Urgent guidance for navigating and circumventing the QTc-prolonging and torsadogenic potential of possible pharmacotherapies for coronavirus disease 19 (COVID-19). Paper presented at the Mayo Clinic Proceedings (Vol. 95, pp. 1213–1221). https://doi.org/10.1016/j.mayocp.2020.03.024. ; Harapan H., Itoh N., Yufika A., Winardi W., Keam S., Te H., Megawati D., Hayati Z., Wagner A. L., Mudatsir M. (2020). Coronavirus disease 2019 (COVID-19): A literature review. Journal of Infection and Public Health, 13, 667–673. https://doi.org/10.1016/j.jiph.2020.03.019. (PMID: 10.1016/j.jiph.2020.03.019) ; Jiang H., Su H., Zhang C., Liu X., Li R., Zhong N., Zhao M. (2020). Challenges of methadone maintenance treatment during the COVID-19 epidemic in China: policy and service recommendations. European Neuropsychopharmacology, 35, 136–137. https://doi.org/10.1016/j.euroneuro.2020.03.018. (PMID: 10.1016/j.euroneuro.2020.03.018) ; Latuskie K. A., Leibson T., Andrews N. C., Motz M., Pepler D. J., Ito S. (2019). Substance use in pregnancy among vulnerable women seeking addiction and parenting support. International Journal of Mental Health and Addiction, 17(1), 137–150. https://doi.org/10.1007/s11469-018-0005-7. (PMID: 10.1007/s11469-018-0005-7) ; Prasad M., Jones M. (2019). Medical complications of opioid use disorder in pregnancy. Paper presented at the Seminars in Perinatology (Vol. 43, pp. 162–167). https://doi.org/10.1053/j.semperi.2019.01.005. ; Qiao J. (2020). What are the risks of COVID-19 infection in pregnant women?The Lancet, 395(10226), 760–762. https://doi.org/10.1016/S0140-6736(20)30365-2. (PMID: 10.1016/S0140-6736(20)30365-2) ; Rothan H. A., Byrareddy S. N. (2020). The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. Journal of Autoimmunity, 109, 102433. https://doi.org/10.1016/j.jaut.2020.102433. (PMID: 10.1016/j.jaut.2020.102433) ; Salisbury-Afshar E. M., Rich J. D., Adashi E. Y. (2020). Vulnerable populations: Weathering the pandemic storm. American Journal of Preventive Medicine, 58, 892–894. https://doi.org/10.1016/j.amepre.2020.04.002. (PMID: 10.1016/j.amepre.2020.04.002) ; Satre D. D., Hirschtritt M. E., Silverberg M. J., Sterling S. A. (2020). Addressing problems with alcohol and other substances among older adults during the COVID-19 pandemic. The American Journal of Geriatric Psychiatry, 28, 780–783 https://doi.org/10.1016/j.jagp.2020.04.012. (PMID: 10.1016/j.jagp.2020.04.012) ; Shainker S. A., Saia K., Lee-Parritz A. (2012). Opioid addiction in pregnancy. Obstetrical & Gynecological Survey, 67(12), 817–825. https://doi.org/10.1097/OGX.0b013e3182788e8c. (PMID: 10.1097/OGX.0b013e3182788e8c) ; Tobon A. L., Habecker E., Forray A. (2019). Opioid use in pregnancy. Current Psychiatry Reports, 21(12), 118. https://doi.org/10.1007/s11920-019-1110-4. (PMID: 10.1007/s11920-019-1110-4) ; Yang H., Wang C., Poon L. (2020). Novel coronavirus infection and pregnancy. Ultrasound in Obstetrics & Gynecology, 55, 435–437. https://doi.org/10.1002/uog.22006. (PMID: 10.1002/uog.22006)
- Entry Date(s): Date Created: 20211202 Date Completed: 20211206 Latest Revision: 20211214
- Update Code: 20231215
|